V

VSL Pharmaceuticals

VSL Pharmaceuticals has agreed to a $20 million class action settlement to resolve claims it falsely advertised the VSL#3 probiotic as clinically proven.

ClosedUnited States-wideClaim status: Closed on October 20, 2026Payout: $800No longer claimable

About this settlement

Allegations of false advertising regarding the VSL#3 probiotic's clinical proof.

This settlement resolves claims that VSL Pharmaceuticals falsely advertised its VSL#3 probiotic as clinically proven. Consumers who purchased VSL#3 in the United States between June 1, 2016, and June 19, 2019, may be eligible for a payment of up to $800.

Who qualifies

  • Consumers who purchased VSL#3 in the United States.
  • Purchases made between June 1, 2016, and June 19, 2019.

$800

Claim status: Closed on October 20, 2026

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

637 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon

Apple logo

Apple

No proof required

Up to $100

Claims opening soon